Leverage COVID-19 home testing Cue Health's FDA-authorized molecular diagnostic test for COVID-19 allows for at-home and over-the-counter use without a prescription. This unique offering presents an opportunity to tap into the growing demand for convenient and accessible testing solutions.

Tailor respiratory test solutions Cue Health's focus on developing a molecular combination test for COVID-19, RSV, and influenza provides a chance to tailor comprehensive respiratory testing solutions. By offering a versatile test designed for over-the-counter and point-of-care use, Cue can address the increasing need for multiplex testing options in the market.

Explore market expansion with clients Cue Health securing a $28 million federal contract to develop a multiplex molecular respiratory test highlights its ability to partner with institutions like the US Department of Health and Human Services. This success can be leveraged to explore opportunities for collaboration with other governmental agencies and healthcare organizations.

Utilize board member connections The appointment of Rishi Reddy to Cue Health's Board of Directors presents a networking opportunity for sales professionals. Leveraging connections and insights from such appointments can open doors to potential partnerships, strategic alliances, or new market ventures.

Identify growth prospects in layoffs Cue Health's recent layoffs indicate a strategic shift to streamline costs and refocus product pipelines. By understanding the areas where Cue is reallocating resources, sales teams can identify potential growth areas or new product offerings that align with the company's revised focus and strategy.